Marie-Claire Orgebin-Crist

Title: Innovator Spotlight: Marie-Claire Orgebin-Crist

Introduction: Marie-Claire Orgebin-Crist is a distinguished inventor based in Nashville, TN, whose contributions to the field of reproductive health and genetics have garnered significant attention. With a focus on understanding male infertility, she has made remarkable strides through her innovative research.

Latest Patents: Orgebin-Crist holds a patent titled "Epididymal lipocalin gene and uses thereof." This invention includes isolated nucleic acids that comprise a lipocalin gene promoter region, isolated nucleic acids encoding a human lipocalin gene, and isolated lipocalin polypeptides among its components. The applications of her patent are both wide-ranging and impactful; they offer potential for generating mouse models of male infertility, facilitating drug discovery screens, and providing therapeutic treatments for fertility-related conditions.

Career Highlights: Throughout her career, Marie-Claire has worked with esteemed institutions, notably Vanderbilt University, where she continues to contribute to groundbreaking research. Her academic background and dedication to the field have resulted in significant advancements in understanding the biological mechanisms underlying male fertility.

Collaborations: In her research endeavors, Orgebin-Crist has collaborated with notable colleagues such as Jean-Jacques Lareyre and Robert J. Matusik. These partnerships highlight the importance of teamwork in scientific innovation and the shared goal of advancing fertility research.

Conclusion: Marie-Claire Orgebin-Crist exemplifies the role of inventors in pushing the boundaries of science and medicine. Her patent on the epididymal lipocalin gene represents a significant advancement that has the potential to impact male fertility treatments and research methodologies in profound ways. As she continues her work, the scientific community looks forward to the contributions she will make in the future.